Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by francois21on Mar 01, 2016 9:19am
394 Views
Post# 24608198

RE:There goes PLI last financial risk.

RE:There goes PLI last financial risk.I'm very please with this financing, as PLI won't have to struggle for money when the bank account will be to low. They are ahead of 6 months as the time line to need a new financing. But my accounting and Financial; point of view will differed from Francois D as I'm not reading a $ 2.54 financing. At expiration of the loan, the mount owing by PLI will be more around $ 48M, that's what a 8% compound interest give on 6.33 years. Technically, PLI could have granted more Something like 10.25 Millions warrants to cover the loan. So the big premium for Thomvest will come from that additionnal 1.5 M of warrants (and the plus value over $4.70). But this will also give PLI extra money over the loan at the end. If Thomvest exercise the warrants before 2022, then more extra money will be in PLI bank account, as the amount owing will less than $ 48M. It's a good deal for both parties...
Bullboard Posts